By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ohr Pharmaceutical 

1245 Brickyard Road
Suite 590
Salt Lake City  Utah  84106  U.S.A.
Phone: 347-753-4389 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Ohr Pharmaceutical (OHRP) Appoints Jason Slakter, MD, Chief Medical Officer, To Board Of Directors 1/8/2015 8:35:44 AM
Ohr Pharmaceutical (OHRP) Reports Fiscal Year 2014 Financial and Business Results 12/23/2014 8:01:19 AM
Ohr Pharmaceutical (OHRP) To Announce Fiscal 2014 Financial Results And Host Conference Call On Monday, December 22 12/19/2014 7:52:33 AM
Ohr Pharmaceutical (OHRP) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/3/2014 4:04:35 PM
Ohr Pharmaceutical (OHRP) To Host Key Opinion Leader Meeting And Webcast On October 31 In New York City 10/27/2014 10:32:59 AM
Ohr Pharmaceutical (OHRP) Announces New Positive Anatomic And Visual Acuity Data On OHR-102 (Squalamine Eye Drops) IMPACT Study Presented At The 2014 American Academy of Ophthalmology Scientific Meeting 10/20/2014 6:29:18 AM
Ohr Pharmaceutical (OHRP) Announces Successful End Of Phase 2 Meeting With The FDA On Squalamine Eye Drops (OHR-102) In Wet AMD 10/14/2014 7:40:24 AM
Ohr Pharmaceutical (OHRP) Announces Squalamine Eye Drop (OHR-102) Clinical Data Presentations At The 2014 American Academy of Ophthalmology Scientific Meeting 10/7/2014 7:46:37 AM
Ohr Pharmaceutical (OHRP) Announces Squalamine Eye Drop (OHR-102) Clinical Data Presentations At The Retina Society 47th Annual Scientific Meeting 9/9/2014 9:02:15 AM
Ohr Pharmaceutical (OHRP) Announces Additional Squalamine Eye Drop (OHR-102) Phase 2 Clinical Data In Wet-AMD; The IMPACT Study 8/13/2014 7:28:57 AM
123456789
//-->